Category: Compliance


Are You Next in Line for a Fiduciary Lawsuit Over Your Supplemental Health Plans?

ERISA fiduciary risks supplemental health plans

A Humaculture® Perspective on Prudent Governance and Created Value

Date: March 10, 2026

Prepared by Humaculture, Inc.

Introduction

Recent ERISA litigation has brought new attention to ERISA fiduciary risks for plan sponsors who manage supplemental health plans. These voluntary benefits include critical illness, accident, and hospital indemnity coverage. In December 2025, class action lawsuits filed by Schlichter Bogard & Denton named both employers and their benefits consultants as defendants. The complaints alleged fiduciary breaches tied to plan oversight, fee reasonableness, and potential conflicts of interest. Cases targeted organizations such as United Airlines, CommonSpirit Health, Allied Universal, and LabCorp. These actions mark an expansion of ERISA scrutiny into health and welfare benefits.

Humaculture, Inc. approaches these challenges with the Humaculture® Topological Model. This framework rests on the maxim “feed the soil, not the plant.” Leaders cultivate the Organization Domain through Processes and Structures as enabling “soil.” This approach empowers People, like “plants,” to thrive within the broader Environment, including Rules (e.g., laws and regulations), and produce sustainable Created Value.

Strong fiduciary governance in benefits programs supports the delivery of the Three Promises as outcomes of the Humaculture® Topological Model: Effectual (tangible risk reduction and compliance), Emotional (trust and fairness), and Economic (cost efficiency and resource optimization).

High-Risk Profile for Supplemental Health Plan Litigation

Industry analysis and patterns from recent cases, including insights referenced in the “Blindsided” paper from Employees First, suggest organizations with the following characteristics face particularly elevated risk:

  • Broker compensation equals or exceeds 30% of premium
  • Total annual premium volume equals or exceeds $10 million
  • High-visibility, nationally recognized brand

If your organization matches this profile, proactive review of fiduciary processes is especially urgent.

Parallel Developments with Retirement Plans

The current wave of supplemental health plan litigation follows the same path that transformed retirement plans over the last two decades. ERISA established the fiduciary framework in 1974. The Pension Protection Act of 2006 and the Tussey v. ABB case in 2012 exposed breaches in recordkeeping and revenue sharing. A wave of excessive fee lawsuits followed, making competitive RFPs, benchmarking, full fee disclosure, and co-fiduciary advisors the new standard. The same combination of legislation plus litigation is now driving a similar paradigm shift in health and welfare benefits. The message is clear: what happened in retirement plans is now happening in supplemental health plans.

ERISA Fiduciary Risks: Actionable Checklist for Plan Sponsors

The checklist below helps Plan Sponsors strengthen their practices to fulfill their fiduciary responsibility for supplemental health plans. Proactive steps reduce litigation exposure. The proactive steps also enhance Well-being as a contributor to productivity, support Merit-Based Talent Cultivation, and build organizational resilience.

The “Blindsided” paper from Employees First (June 2025) was referenced in each of these lawsuits, both in the narrative and footnotes, as supporting context for longstanding concerns about these issues. The paper focuses primarily on employers as plan sponsors because the document is geared toward them as the ultimate fiduciaries under ERISA. While the lawsuits name four consultants/brokers (Mercer, Gallagher, Lockton, and WTW) as co-defendants, the paper emphasizes employers’ responsibility to oversee and select advisors prudently. It argues that plan sponsors bear the primary duty to act in participants’ best interests, even if consultants contribute to issues like excessive fees or conflicts. The root cause is often portrayed as a systemic failure in fiduciary processes, but the paper prioritizes actionable steps for employers rather than assigning blame to brokers, to empower sponsors to mitigate risks independently.

Fiduciary Risk Mitigation Checklist for Supplemental Health Plans

Apply this checklist during annual reviews, vendor evaluations, or plan design updates. Document decisions thoroughly to create a prudent process trail.

  1. Strengthen Governance Through Dedicated Structures
    • Form or reinforce a benefits committee with a clear charter. The charter must emphasize ERISA duties of prudence, loyalty, and exclusive participant benefit.
    • Include independent expertise and establish Processes for regular training.
    • Action Item: Schedule annual fiduciary education and review committee composition within 60 days.
  2. Formalize Vendor and Consultant Selection Processes
    • Conduct competitive requests for proposals with full compensation disclosure, including all overrides, production credits, and revenue-sharing arrangements.
    • Prioritize fee-only advisors willing to accept co-fiduciary status under ERISA sections 3(21) or 3(38) to minimize conflicts.
    • Action Item: Initiate an RFP cycle if current arrangements exceed three years.
  3. Ensure Fee Reasonableness and Transparency
    • Identify, itemize, and benchmark all fees, services, overrides, production credits, and potential outcomes against industry standards to maximize participant Created Value. Ensure supplemental health plans are not paying a disproportionate share of administrative services.
    • Evaluate claims payout ratios and overall participant value.
    • Action Item: Engage independent benchmarking and negotiate adjustments where costs appear excessive.
  4. Align Plan Design with Participant Needs and Created Value
    • Confirm offerings provide meaningful, non-duplicative coverage.
    • Deliver clear, annual disclosures on costs, benefits, and oversight.
    • Action Item: Update Summary Plan Descriptions and gather participant feedback via surveys.
  5. Embed Ongoing Monitoring via Enabling Processes
    • Establish quarterly performance metrics for enrollment, claims efficiency, and satisfaction.
    • Use information gathered from Performance Nurturing process to adapt offerings dynamically.
    • Action Item: Implement monitoring dashboards and schedule regular committee discussions.
  6. Secure Protections and Continuous Adaptation
    • Maintain robust fiduciary liability coverage that includes health plans.
    • Develop response protocols for regulatory inquiries.
    • Action Item: Conduct an annual insurance review and consider a simulated fiduciary audit.

How Humaculture® Can Support Your Organization

Humaculture, Inc. helps leaders cultivate resilient organizations with the Humaculture® Topological Model and tools such as the HARS™ (Health, Absence, Resilience Support) framework. We offer independent assessments of total rewards programs, including supplemental health plan governance, without the product sales conflicts of many brokers and consultants. Explore our full range of services and support options.

Independent Consultant vs. Traditional Broker

The choice of advisor is one of the most important Processes in the Organization Domain. Choosing an independent consultant instead of a traditional broker is a direct way to “feed the soil” of strong fiduciary governance. Here is how the two approaches compare:

Note: Many large firms that market themselves as “consultants” continue to earn the majority of revenue from carrier commissions, overrides, and production-based fees — operating with the same conflicts as traditional brokers. True independence requires client-paid fees only and acceptance of co-fiduciary responsibility.

AspectIndependent ConsultantTraditional Broker
Type of FirmProfessional advisory firm licensed to advise on insuranceInsurance agency or brokerage
Primary Revenue SourceClient-paid feesCarrier-paid commissions
Pricing ModelFixed or project-based feesPercentage of premium (typically 25–40%)
Revenue Sharing / OverridesNoneCommon (overrides, sales quotas, production bonuses)
RepresentsThe plan sponsor / clientThe insurance carriers
Primary FocusStrategic design, participant outcomes, Created ValueProduct placement and premium volume
Service StyleComprehensive RFP, actuarial analysis, ongoing monitoringTransactional renewals and carrier-driven
SummaryUnbiased strategic guidance serving only client interestsServices designed to support product sales and servicing

ERISA Fiduciary Risks Alignment with the Humaculture® Topological Model

The table below shows how an independent consultant strengthens the Organization Domain in the Humaculture® Topological Model by feeding the soil of clean Processes. In short, the broker model fails to recognize how Processes enable healthy Connections between the Organization Domain and People, creating unintended consequences.

AspectHumaculture® AlignmentPractical Outcome in the Model
Primary Revenue Source & Pricing ModelClient-paid fees vs. carrier commissionsClean “soil” (no hidden conflicts) vs. contaminated “soil”
Revenue Sharing / OverridesNone vs. common overridesProtects integrity of the fiduciary Processes vs. self-dealing
RepresentsPlan sponsor vs. insurance carriersFeeds loyalty and prudence vs. violates exclusive-benefit rule
Primary Focus & Service StyleStrategic design and Created Value vs. product placementNurtures Created Value vs. treats People as sales opportunity
SummaryUnbiased guidance vs. product sales supportCultivates resilient Organization Domain vs. creates unintended consequences

Our services cover fiduciary process audits aligned with the Dynamic Matrix, evidence-based plan design recommendations, actuarial-supported ROI modeling for benefits investments, and Cultural Nurturing strategies to enhance engagement and Well-being.

We focus on Merit-Based Talent Cultivation and Equality of Opportunity to deliver balanced outcomes in each of the Three Promises.

ERISA Fiduciary Risks Summary

The evolving ERISA landscape calls for robust, documented fiduciary Processes in supplemental health plans. Leaders who proactively feed the soil through strong governance reduce legal risks and unlock greater Created Value. This includes lower costs, higher resilience, and sustained productivity. Read more of our insights on organizational resilience.

Humaculture, Inc. stands ready to partner with you on this cultivation journey. Contact us to discuss a customized assessment or explore how the Humaculture® Topological Model can optimize your total rewards strategy.

Contact: Steve Cyboran at [email protected], Wes Rogers at [email protected], or Caroline Cyboran at [email protected]

Website: humaculture.com

X: @HumacultureInc

LinkedIn: humaculture-inc

Hidden Opportunities, A Strategic Compliance Series

Hidden Opportunities Overview

In this webinar series we explore ways organizations can go beyond basic compliance and improve their “organizational soil” through a strategic response to the No Surprises Act and the Transparency in Coverage regulations. Our goal is to help organizations create a competitive advantage. Does it make sense to expend limited resources to merely comply with the law and regulations, or is there a way to strategically “design the compliance away” while differentiating the employee value proposition?

For example, a knowledgeable horticulturist may use the high temperatures of the summer season, which are a normal part of the environment just as law and regulation are a normal part of the business environment, to solarize the soil. This is a low cost and simple process of spreading a plastic sheet over an area of soil to trap and intensify the sun’s energy. It is a process that works well to destroy weed seeds and pathogens. Similarly, a knowledgeable Humaculturist® can employ techniques to leverage laws and regulations to strategically improve the organization. This webinar series seeks to identify some of these techniques.

The topics from the series include:

Hidden Opportunities: No Surprises Act
Surpassing Mere Compliance – Including Reference Based Pricing
Preserving the Harvest…Leveraging HSAs
Hidden Opportunities: Transparency
A “Dope” Response to Pharmacy Transparency
Mental Health Parity…A Lucid Approach
Pest Management, Minimizing Plan Losses through Fee Disclosure

Available Support

We are available to support you in your strategy, design, compliance, financial, and monitoring needs. Our team includes experts in organization design, actuarial science, clinical, and legal can guide the process to achieve optimal behavior. Please contact us.

Compliance Toolkit Fourth Quarterly Update Released

Compliance-Toolkit-Overview-1

The Compliance Toolkit fourth quarterly update was released on October 31, 2022 for changes since it was released on November 11, 2021.  The Consolidated Appropriations Act (CAA)No Surprises Act, and Transparency in Coverage Final Rule Compliance toolkit will next be updated on or around January 31, 2023 if there are any updates required.

Compliance Toolkit First Quarterly Update

The Compliance Toolkit first quarterly update addresses:

  • The Independent Dispute Resolution section was updated to include a section for the Revenue Procedure 2022-11 which published the percentage adjustment for median contracted rates.
  • The Pharmacy Benefit and Drug Cost Reporting section was updated to include a section reflecting the guidance contained in the November 23, 2021 Prescription Drug and Health Care Spending Interim Final Rules, implementing Section 204, Title II, another phase of the transparency provisions of the Consolidated Appropriations Act (CAA) of 2021. 
  • The Direct and Indirect Compensation section was updated to reflect clarifying language and a section was added to address guidance contained in the Field Assistance Bulletin No. 2021-03 released by the Department of Labor (“DOL”) on December 30, 2021.
  • Attachment 1: Compliance Tool – CAA and Transparency Financial Impact Analysis Tool was updated to reflect additional calculations.
  • Attachment 9: Compliance Tool – MHPAEA Comparative and Fee Analysis Tool was updated to improve some of the functionality.

Compliance Toolkit Second Quarterly Update

The Compliance Toolkit second quarterly update addresses:

  • The Initiation of IDR Process section was updated to indicate that online IDR portal was opened on April 15, 2022.
  • The Determination of Payment section was updated to report a court case that invalidated the portion of the interim final rule relating to the presumption that the QPA is the most appropriate amount and a release of a Memorandum, withdrawing the portion of the interim final rule that was invalidated by the court.
  • The Petition to Deny or Revoke IDR Certification was updated to report the release of IRS Notice 2022-11, which provides guidance on indexing “the qualifying payment” amount for items and services furnished in 2022 in the case of a group health plan or insurer that does not have enough information as of January 31, 2019, to calculate the median of the in-network contracted rates or in the case there are new items or services being furnished.
  • The Fee Disclosure Related to Covered Group Health Plans Section was updated to remove duplicate sections.
  • The Public Disclosure of Provider Fees Requirement section was updated to report the release of two new FAQs discussing the machine-readable files used for public disclosure.

Compliance Toolkit Third Quarterly Update

The Compliance Toolkit third quarterly update addresses:

  • The “Independent Dispute Resolution (IDR) Procedures for Determining Certain Out-of-Network Rates to Be Paid by Group Health Plans” section has been updated to reflect the following:
    • Departments jointly issued FAQ guidance adopting an enforcement safe harbor for health plans and insurers reporting certain types of in-network rates under the transparency in coverage.
    • Departments jointly issued revised process guides for independent dispute resolution (IDR) under the No Surprises Act.
    • Federal Court stays proceeding in case vacating Portions of No Surprises Act’s IDR Regulations
    • Departments Jointly issued Checklist for Surprise Billing IDR Process
    • Departments Issued Checklist for Surprises Billing IDR process
  • The “Public Disclosure of Provider Fees Requirement” section was updated to clarify that the deadline for posting the Machine Readable Files is July 1, 2022.

Compliance Toolkit Fourth Quarterly Update

The Compliance Toolkit fourth quarterly update addresses:

  • Federal Court vacated key portions of the interim final regulation implementing the independent dispute (IDR) provisions of the No Surprises Act relating to air ambulance services.
  • The DOL, HHS and IRS finalized options of the No Surprise Act medical billing regulation covering the independent dispute resolution (IDR) process. These regulations first remove the provision that the court invalided and specify that certified IDR entities should select the offer that represents the value of the item or service under dispute after considering the QPA and all permissible information submitted by the parties. The regulation net expanded on the requirement that health plans and insurers disclosure to provided and facilities the QPA for items or services with each initial payment or notice of denial of payment.
  • In connection with the release of the final Surprise Billing regulations, the Departments of Labor (“DOL”), Health and Human Services (“HHS”) and Treasury (collectively, the “Agencies”) released an extensive set of FAQs covering surprise billing and price transparency rules.  The FAQs are wide-ranging, but provide important clarifications.
  • CMS published more detailed reporting guidance along with reporting templates on its RxDC webpage for Prescription Drug reporting due on December 27, 2022. This guidance included the following:
    • RxDC reporting instructions
    • RxDC templates
    • RxDC drug name and therapeutic class crosswalk
  • CMS also revised the Model Disclosure Notice Regarding Patient Protections Against Surprise Billing and its instructions and the Standard Notice and Consent Documents Under the No Surprises Act to be used in 2022 and to be used in 2022 and beyond.
    • Attachment 2 now reflects the recently released revised “Model Disclosure Notice Regarding Patient Protections Against Surprise Billing.”
    • Attachment 3 now reflects the recently released revised “Standard Notice and Consent Documents Under the No Surprises Act.”

Compliance Toolkit Contents

To address the compliance needs of the industry, Humaculture, Inc. partnered with Attorneys Howard Lapin and Larry Grudzien to create a Compliance Toolkit to address all of the requirements in the new law and regulations. It contains over forty documents, including:

  • A detailed explanation of the law and regulations;
  • A compliance tool that highlights all of the required changes and what steps needed to be taken to comply;
  • Sample provisions for plan documents, Summary Plan Descriptions, and administrative services agreements;
  • All of the model notices that have to be provided to covered individuals;
  • Sample notices that have to be provided to participants; and
  • Sample disclosures and reports that have to be made to the governmental agencies.

There are over two hundred and eighty-five (285) pages of documents in this Compliance Toolkit. It has been specially designed for use by employers, insurers, brokers, and third-party administrator to help them effectively to comply with all of the requirements.

Webinar Reviewing the Compliance Toolkit

On December 14, 2021, we conducted a free webinar to review the Compliance Toolkit. We reviewed its contents and explained how it can be used to comply with the requirements. You can view the webinar here.

Hidden Opportunities, A Strategic Compliance Series

Humaculture, Inc. conducted a strategic compliance webinar series over the first five months of 2022 focusing on harnessing the Hidden Opportunities in the No Surprises Act and Transparency in Coverage Final Rule. Our goal was to help organizations create a competitive advantage. Does it make sense to expend limited resources to merely comply with the law and regulations, or is there a way to strategically “design the compliance away” while strategically differentiating the employee value proposition?

Ordering

You can purchase the Compliance Toolkit, which includes quarterly updates through October 31, 2023, for only $450 by contacting us and we will invoice you for the purchase price. Contact us to order your own copy or to ask any questions.

Available Support

We are available to support you in your compliance and financial needs. This Compliance Toolkit, including Financial Analysis Tools will help facilitate self compliance. Our team of consultants, including actuaries, clinicians, behavioral health, pharmacy, and legal resources are also available to guide you through the compliance process, or we can take the lead. We would be happy to have a conversation regarding your needs and can customize a proposal for the level and type of support you may need. Please contact us.

Webinar Replay: Pest Management, Minimizing Plan Losses through Fee Disclosure

Pest Management, Minimizing Plan Losses through Fee Disclosure

Watch a replay of the fifth webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, which focuses on how to use fee disclosure to leverage behavioral design, seek strategic advisors, and optimize plan efficiency.

Presenters

  • Steve Cyboran, ASA, MAAA, FCA, CEBS, actuary and strategy consultant
  • Wes Rogers, Humaculturist® and strategy consultant
  • Jack Towarnicky, LLM, JD, MBA, CEBS, attorney, strategy and compliance consultant

Objective

Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act and Transparency in Coverage to create a competitive advantage for both the employer and employees.  This session focuses on how leveraging Fee Disclosure as a means of “Pest Management” to leverage behavioral design to align interests with your advisors to take a strategic approach and identify conflicts of interest and inferior value in services provided.

Fee Disclosure Key Takeaways

During this session, participants will learn that:

  • It seems Congress doesn’t believe group health plan fiduciaries are knowledgeable about fees
  • This may be a first step to shine light on fee reasonableness, conflicts of interest
  • While the plan fiduciary remains responsible, advisors are put on notice to disclose
  • Mere compliance ignores the opportunity to cultivate the organizational soil
  • Leveraging Fee Disclosure as a means of “Pest Management” can:
    • Identify conflicts of interest and inferior value in services provided
    • Avoid advisors who haven’t already fully disclosed their compensation
    • Seek advisors who take a strategic approach, cultivate your organizational soil
    • Employ behavioral design to align interests

Available Support

We are available to support you in your strategy, design, compliance, financial, and monitoring needs. To that end, our team of consultants, including actuaries, clinicians, behavioral health, pharmacy, and legal resources are available to guide you through the strategy and compliance process. Please contact us: [email protected].

Watch

Watch the Hidden Opportunities: Pest Management, Minimizing Plan Losses through Fee Disclosure Webinar Replay below, or via Rumble or YouTube.

Hidden Opportunities: Pest Management, Minimizing Plan Losses through Fee Disclosure

Pest Management, Minimizing Plan Losses through Fee Disclosure

Join us on Thursday, May 19 from 12:00 to 12:30 CST for the fifth webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, to learn how to use fee disclosure to leverage behavioral design, seek strategic advisors, and optimize plan efficiency.

Presenters

  • Steve Cyboran, ASA, MAAA, FCA, CEBS, actuary and strategy consultant
  • Wes Rogers, Humaculturist® and strategy consultant
  • Jack Towarnicky, LLM, JD, MBA, CEBS, attorney, strategy and compliance consultant

Objective

Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act and Transparency in Coverage to create a competitive advantage for both the employer and employees. In this session we will include a focus on how leveraging Fee Disclosure as a means of “Pest Management” to leverage behavioral design to align interests with your advisors to take a strategic approach and identify conflicts of interest and inferior value in services provided.

Fee Disclosure Key Takeaways

During this session, participants will learn that:

  • It seems Congress doesn’t believe group health plan fiduciaries are knowledgeable about fees
  • This may be a first step to shine light on fee reasonableness and conflicts of interest
  • While the plan fiduciary remains responsible, advisors are put on notice to disclose
  • Mere compliance ignores the opportunity to cultivate the organizational soil
  • Leveraging Fee Disclosure as a means of “Pest Management” can:
    • Identify conflicts of interest and inferior value in services provided
    • Avoid advisors who haven’t already fully disclosed their compensation
    • Seek advisors who take a strategic approach, cultivate your organizational soil
    • Employ behavioral design to align interests

Webinar Replay: Mental Health Parity…A Lucid Approach

Mental Health Parity…A Lucid Approach

Watch a replay of the fourth webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, which focuses on why mental health issues, costs, and administration continue to increase despite Mental Health Parity efforts and how to effectively respond.

Presenters

  • Steve Cyboran, ASA, MAAA, FCA, CEBS, actuary and strategy consultant
  • Wes Rogers, Humaculturist® and strategy consultant
  • Jack Towarnicky, LLM, JD, MBA, CEBS, attorney, strategy and compliance consultant

Objective

Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act and Transparency in Coverage to create a competitive advantage for both the employer and employees. This session focuses on how investing in the organizational soil is “A Lucid Approach” and an example of a strategic action to build organizational resilience and mental fitness by leveraging the purpose, alignment, and health of the organization.

Mental Health Parity Key Takeaways

During this session, participants will learn:

  • Mental Health Parity in health benefits has not reduced mental health issues
  • In fact, mental health issues continue to increase despite efforts to equalize benefits
  • Mere CAA compliance will increase costs and administration
  • How investing in the soil is “A Lucid Approach” and an example of a strategic action to:
    • Avoid what can be avoided
    • Leverage the purpose, alignment, and health of the organization
    • Build organizational resilience and mental fitness
    • Communicate all negatives as the result of compliance
    • Leverage behavioral design to achieve meaningful impact

Available Support

We are available to support you in your strategy, design, compliance, financial, and monitoring needs. To that end, our team of consultants, including actuaries, clinicians, behavioral health, pharmacy, and legal resources are available to guide you through the compliance process. Please contact us: [email protected].

Watch

Watch the Hidden Opportunities: Preserving the Harvest…Leveraging HSAs Webinar Replay below, or via Rumble or YouTube.

Hidden Opportunities: Mental Health Parity…A Lucid Approach

Mental Health Parity…A Lucid Approach

Join us on Thursday, April 21 from 12:00 to 12:30 CST for the fourth webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, to learn why mental health issues, costs, and administration continue to increase despite Mental Health Parity efforts and how to effectively respond.

Presenters

  • Steve Cyboran, ASA, MAAA, FCA, CEBS, actuary and strategy consultant
  • Wes Rogers, Humaculturist® and strategy consultant
  • Jack Towarnicky, LLM, JD, MBA, CEBS, attorney, strategy and compliance consultant

Objective

Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act and Transparency in Coverage to create a competitive advantage for both the employer and employees. In this session we will include a focus on how investing in the organizational soil is “A Lucid Approach” and an example of a strategic action to build organizational resilience and mental fitness by leveraging the purpose, alignment, and health of the organization.

Mental Health Parity Key Takeaways

During this session, participants will learn:

  • Mental Health Parity in health benefits has not reduced mental health issues
  • In fact, mental health issues continue to increase despite efforts to equalize benefits
  • Mere CAA compliance will increase costs and administration
  • How investing in the soil is “A Lucid Approach” and an example of a strategic action to:
    • Avoid what can be avoided
    • Leverage the purpose, alignment, and health of the organization
    • Build organizational resilience and mental fitness
    • Communicate all negatives as the result of compliance
    • Leverage behavioral design to achieve meaningful impact

Webinar Replay: A “Dope” Response to Pharmacy Transparency

A "Dope" Response to Pharmacy Transparency

Watch a replay of the third webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, which focuses on why the new pharmacy transparency law will not increase transparency; will increase costs, administration, and litigation risk; and how to effectively respond.

Presenters

Objective

Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act to create a competitive financial advantage for both the plan sponsor and plan participants. This session focuses on leveraging Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as an example of a strategic action organizations can take to optimize this compliance opportunity.

Pharmacy Transparency Key Takeaways

During this session, participants will learn:

  • Transparency is a misnomer – New rules don’t provide transparency
  • Pharmacy is likely to continue to be rather “opaque”
  • The conundrum – mere compliance will likely increase costs, administration, and litigation risk
  • How to use Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as examples of strategic actions to:
    • Avoid what can be avoided
    • Provide true transparency with pharmacy benefits
    • Empower consumers to make better, more clinically appropriate decisions
    • Communicate all negatives as the result of compliance
    • Inform/educate consumers (before they become patients)

Available Support

We are available to support you in your strategy, design, compliance, financial, and monitoring needs. To that end, our team of consultants, including actuaries, clinicians, behavioral health, pharmacy, and legal resources are available to guide you through the compliance process. Please contact us: [email protected].

Watch

Watch the Hidden Opportunities: Preserving the Harvest…Leveraging HSAs Webinar Replay below, or via Rumble or YouTube.

Hidden Opportunities, A Strategic Compliance Series: A “Dope” Response to Pharmacy Transparency

A "Dope" Response to Pharmacy Transparency

You can now access a replay of this webinar here.

Join us on Thursday, March 17 from 12:00 to 12:30 CST for the third webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, to learn why the new pharmacy transparency law will not increase transparency; will increase costs, administration, and litigation risk; and how to effectively respond.

Presenters

Objective

Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act and Transparency in Coverage to create a competitive advantage for both the employer and employees. In this session we will include a focus on leveraging Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as an example of a strategic action organizations can take to optimize this compliance opportunity.

Pharmacy Transparency Key Takeaways

During this session, participants will learn:

  • Transparency is a misnomer – New rules don’t provide transparency
  • Pharmacy is likely to continue to be rather “opaque”
  • The conundrum – mere compliance will likely increase costs, administration, and litigation risk
  • How to use Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as examples of strategic actions to:
    • Avoid what can be avoided
    • Provide true transparency with pharmacy benefits
    • Empower consumers to make better, more clinically appropriate decisions
    • Communicate all negatives as the result of compliance
    • Inform/educate consumers (before they become patients)
Next page →